Exelixis Inc (NAS:EXEL)
$ 35.81 -0.04 (-0.11%) Market Cap: 10.23 Bil Enterprise Value: 9.24 Bil PE Ratio: 22.96 PB Ratio: 4.50 GF Score: 91/100

Exelixis Inc at Guggenheim Partners Oncology Day Transcript

Feb 14, 2019 / 02:00PM GMT
Release Date Price: $22.3 (+1.13%)
Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD

Are we good? Okay. Good morning. My name is Michael Schmidt. I'm one of the biotech analysts at Guggenheim Securities. It is my great pleasure to welcome the first company this morning, Exelixis.

With us today, we have Michael Morrissey, President and CEO. Michael, welcome. Thanks so much for joining us.

Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director

Good morning.

Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD

And before we kick in into some very difficult Q&A...

Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director

There you go. Give me some...

Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD

Why don't you just give some very brief overview of the story, just to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot